NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/28/2023
Back to search
Official data from USPTO
CERTIFIED GERIATRIC PHARMACIST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CERTIFIED GERIATRIC PHARMACIST
ST13
US500000085487409Class
-
Filing
85487409
Registration
4300066
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
09/28/2023
Classification
Registered
Trademark type
Word
Nice classes
-
Filing date
12/05/2011
Registration date
03/12/2013
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2023
Last transaction
09/28/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Drawing code
4
Owner type
54
Owner location
WASHINGTON, DC, US
Examiner
BIBBINS, ODESSA
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
AMERICAN PHARMACISTS ASSOCIATION
Commission For Certification In Geriatric Pharmacy, Inc.
Representatives
Gregory M. Stone Whiteford, Taylor & Preston, LLP
Technical classification
Nice Classes
No classes reported.
Vienna Codes
No Vienna codes available.
Goods and services
No goods and services specifications.
Publications
History of USPTO decisions and trademark events.
38 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/28/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/28/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/20/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/19/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
03/13/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/12/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/17/2019
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
05/17/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/17/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/07/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/03/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2019
E815
TEAS SECTION 8 & 15 RECEIVED
03/12/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/18/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2013
PUBO
PUBLISHED FOR OPPOSITION
12/25/2012
NPUB
NOTICE OF PUBLICATION
12/05/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/20/2012
CNEA
EXAMINERS AMENDMENT MAILED
11/19/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2012
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/19/2012
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/04/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/25/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
09/20/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2012
PAPER RECEIVED
09/04/2012
CNRT
NON-FINAL ACTION MAILED
03/26/2012
CNRT
NON-FINAL ACTION WRITTEN
03/24/2012
DOCK
ASSIGNED TO EXAMINER
03/15/2012
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/30/2012
ALIE
ASSIGNED TO LIE
01/19/2012
PAPER RECEIVED
01/06/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2011
NWAP
NEW APPLICATION ENTERED
12/08/2011
Continuous trademark protection
Get notified about every new filing that threatens CERTIFIED GERIATRIC PHARMACIST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.